Nasdaq:US$17.44 (-0.10) | HKEX:HK$27.60 (+0.68) | AIM:£2.57 (+0.1)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF